April 22, 2018 / 5:21 AM / a month ago

BRIEF-Saudi's Al Hammadi Signs MOU With Sudair Pharma For Acquisition Of Equity Stake

April 22 (Reuters) - AL HAMMADI COMPANY FOR DEVELOPMENT AND INVESTMENT:

* SIGNS MOU WITH SUDAIR PHARMA COMPANY FOR ACQUISITION OF EQUITY STAKE

* TERM OF MOU IS TWO MONTHS FROM DATE OF SIGNING MOU APRIL 21, 2018 AND WILL END ON JUNE 20, 2018

* THE ACQUISITION IS IN LINE WITH AL HAMMADI’S GROWTH PLANS AND THE KINGDOM VISION 2030 TO NATIONALIZE ADVANCED INDUSTRIES AND TECHNOLOGIES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below